The Myositis Association (TMA) offers a competitive research grant program with the goal of advancing our understanding of the causes, prevention, detection, treatment, and finding a cure for all types of immune-mediated myositis. During the 2024 grant cycle, our request for proposals targets projects specifically related to inclusion body myositis and juvenile myositis.
TMA’s 2024 Research Grant Program Guidelines provide specifics about our current request for proposals and the procedures and conduct of the research program.
Inclusion body myositis (IBM) – One award of up to $80,000 will be granted for a disease-specific targeted project that adheres to specific guidelines as outlined in the 2024 Research Grant Program Guidelines. This funding is provided over a one-year period.
Juvenile myositis (JM) – One award of up to $45,000 will be granted for a disease-specific targeted project that advances the understanding of the cause, prevention, detection, treatment, or cure of juvenile myositis diseases. This funding is provided over a one-year period.
Timeline for the 2024 Grant Program
Letter of Intent due May 24, 2024
Invitation for full application by June 3, 2024
Full application due July 15, 2024
Notification of awards November 2024
Earliest funding starts January 2025
Both applications require information in NIH Biosketch format.
See Research Grant Program FAQs
For more information contact us at linda@myositis.org.